Impact of Obesity on Target Organ Damage in Patients with Metabolic Syndrome.
Svetlana KostićIvan TasićNikola StojanovićJelena RakocevicMarina Deljanin IlićDragan ĐorđevićViktor StoičkovIsidora TasićPublished in: Diagnostics (Basel, Switzerland) (2024)
MetSy and obesity significantly alter the levels of NO metabolites, iNOS, ox-LDL-Chol, and PAI-1. High prevalence of NAFLD in obese patients with MetSy requires active screening and treatment of potential risk factors.
Keyphrases
- metabolic syndrome
- insulin resistance
- weight loss
- risk factors
- type diabetes
- uric acid
- high fat diet induced
- cardiovascular risk factors
- adipose tissue
- oxidative stress
- ms ms
- weight gain
- bariatric surgery
- skeletal muscle
- low density lipoprotein
- nitric oxide synthase
- cardiovascular disease
- obese patients
- smoking cessation
- replacement therapy